1. Companies

  2. THEON Therapeutics

THEON Therapeutics

THEON Therapeutics

Verified
A biopharmaceutical company developing small molecules that inhibit the immunosuppressive cancer signaling pathways.
Launch date
Employees
11-50 people
Market cap
-
Net debt
-
Enterprise valuation
$11—17m (Dealroom.co estimates Feb 2021.)
Cambridge Massachusetts (HQ)
https://www.THEONTx.com
https://twitter.com/nickdavisscdhttps://www.linkedin.com/company/theontx/
    • Edit
Get premium to view all results
DateInvestorsAmountRound
N/A

$0.0

round
*
N/A

$2.9m

Early VC
Total Funding000k

RELATED LANDSCAPES AND LISTS

Related Content

Recent News about THEON Therapeutics

Edit